The safety of medicines is a major concern for both the medical community and pharmaceutical industries alike. Against this backdrop, The Clinical Services Journal reports on a recent conference organised by the MHRA focusing on current experience and future directions within this area.
Log in or register FREE to read the rest
This story is Premium Content and is only available to registered users. Please log in at the top of the page to view the full text.
If you don't already have an account, please register with us completely free of charge.
